Tuesday, October 31, 2006

EYE CONDITIONS IN TRAUMATIC BRAIN INJURY

Taylor & Francis Journals: "Conditions with high relative risk unique to TBI included corneal abrasion, blepharitis, chalazion/hordeolum, dry eye, traumatic cataract, vitreal prolapse and optic atrophy. This is distinct from those ophthalmic conditions unique to CVA, which included sub-conjunctival haemorrhage and ptosis."

"

Wednesday, October 25, 2006

ACE INHIBITOR IN NORMAL TENSION GLAUCOMA

ScienceDirect - American Journal of Ophthalmology : Prevention of Visual Field Defect Progression With Angiotensin-Converting Enzyme Inhibitor in Eyes With Normal-tension Glaucoma
To report the effect of angiotensin-converting enzyme (ACE) inhibitor on visual field changes in normal-tension glaucoma (NTG). Although the present study is retrospective and the sample size is small, ACE inhibitor might have a favorable effect on the visual field in patients with NTG in this small study.

EYESTRAIN COMPLAINT IN CHILDREN

ScienceDirect - American Journal of Ophthalmology : Prevalence of Eye Disorders in Young Children With Eyestrain Complaints: "Most children complaining of eyestrain had a normal eye examination; whereas most children with refractive error, amblyopia, or strabismus were free of eyestrain, making this complaint a poor marker of eye conditions in young children. "

Monday, October 23, 2006

Travatan Z Approved by FDA


The first and only prostaglandin analogue without BAK is now available. Travatan Z manufactured by Alcon has just received approval. This may help alleviate the stinging and redness often associated with prostaglandin analogues.
See Alcon's Website for more information.

Tuesday, October 17, 2006

EyeWorld Magazine: October 2006

EyeWorld Magazine: October 2006

Article about how smokeless tobacco is an even higher risk for cataract development than is smoking.